{
  "id": 16500783,
  "title": "Personalized cancer vaccine cuts risk of recurrence and death by 42%",
  "url": "https://urgent.news/2026/10/25/personalized-cancer-vaccine-cuts-risk-of-recurrence-and-death-by-42",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-25T16:54:20.000Z",
  "source": {
    "name": "Ajel English",
    "slug": "ajel-english",
    "url": "https://english.ajel.sa/lifestyle/wzwzhxtdi"
  },
  "original_language": "en",
  "account": "A clinical trial has demonstrated that a personalized cancer vaccine, when combined with immunotherapy, can lower the risk of melanoma returning or causing death by 42%. This groundbreaking vaccine, developed by MSD and Moderna, uses messenger RNA (mRNA) technology and is custom-made for each patient based on their tumor's genetic information. The trial, involving 1,137 adults, showed that patients receiving the vaccine alongside the immunotherapy drug Keytruda were 38% less likely to experience melanoma recurrence or spread over two years compared to those who received immunotherapy alone. While the results are promising, experts emphasize the need for longer studies to determine whether the treatment truly extends patients' lives. The vaccine's potential for wider use is being explored in other cancers, including kidney, bladder, and lung cancer. However, the cost of personalized treatment and the need for genetic analysis of each patient's tumor may limit its widespread accessibility within the UK's National Health Service.",
  "summary": "A large clinical trial found a new personalized cancer vaccine reduced the risk of melanoma returning or causing death by 42% when combined with immunotherapy.",
  "key_points": [
    "Personalized cancer vaccine reduces melanoma recurrence/death risk by 42%",
    "MSD and Moderna developed mRNA-based vaccine using patient's tumor genetic info",
    "Trial of 1,137 adults showed 38% lower recurrence/spread with vaccine+Keytruda"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}